Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study - 14/05/24
Doi : 10.1016/j.jaad.2024.01.070
Rachel M. Reardon, BS a, b, Katherine L. Perlman, MPH a, c, Maria S. Asdourian, MPhil a, b, Nishi Shah, BS a, Ted V. Jacoby, BS a, Leah L. Thompson, MD a, Kerry L. Reynolds, MD d, Yevgeniy R. Semenov, MD, MA a, Steven T. Chen, MD, MPH, MS-HPEd a, b, ⁎ 
a Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
b Harvard Medical School, Boston, Massachusetts
c University of Illinois College of Medicine, Chicago, Illinois
d Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts
∗Correspondence to: Steven T. Chen, MD, MPH, MS-HPEd, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, 50 Staniford St, Ste 200, Boston, MA 02114Department of DermatologyMassachusetts General Hospital and Harvard Medical School50 Staniford StSte 200BostonMA02114
Key words : dermatologic immune-related adverse events, immune checkpoint inhibitor, immunotherapy, oncology
| Authors Reardon and Perlman contributed equally to this work. |
|
| Funding sources: Dermatology Foundation Medical Dermatology Career Development Award (Dr Chen). |
|
| Elements of this work to be included in a presentation at the World Congress of Dermatology, Singapore, July 7 2023. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Approved by the Institutional Review Board of Mass General Brigham (#2017P000501). |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 90 - N° 6
P. 1268-1271 - juin 2024 Retour au numéro
Article précédent
- Combining artificial intelligence and human expertise for more accurate dermoscopic melanoma diagnosis: A 2-session retrospective reader study
- Mario Giulini, Mohamad Goldust, Stephan Grabbe, Christian Ludwigs, Dominik Seliger, Priyanka Karagaiah, Hadrian Schepler, Florian Butsch, Beate Weidenthaler-Barth, Stephan Rietz
- Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients
- Heather A. Brandling-Bennett, Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo-Soccio, Dominic O. Co, Kelly M. Cordoro, Megan L. Curran, Austin M. Dalrymple, Carsten Flohr, Ken B. Gordon, Diane Hanna, Alan D. Irvine, Susan Kim, A. Yasmine Kirkorian, Irene Lara-Corrales, Jill Lindstrom, Amy S. Paller, Melissa Reyes, Wendy Smith Begolka, Wynnis L. Tom, Abby S. Van Voorhees, Ruth Ann Vleugels, Lara Wine Lee, Olivia Davies, Elaine C. Siegfried
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?